SAN FRANCISCO, May 19, 2009 – New data demonstrate that maintenance therapy with RISPERDAL® CONSTA® (risperidone) Long-Acting Treatment (RLAT) significantly delayed the time to relapse compared to ...
21 September 2003 – Prague – When used alone, RISPERDAL® (risperidone) significantly improves symptoms of acute mania in persons with bipolar disorder as early as one week after treatment begins, ...
Study of risperidone began in the late s and it was approved for sale in the United States in Risperidone is mainly used for the risperidone (risperdal) 1mg tablet of schizophrenia, bipolar disorder, ...
The U.S. Food and Drug Administration approved the first generic versions of Risperdal (risperidone) tablets. Risperdal is an antipsychotic drug used for the treatment of schizophrenia, bipolar ...
Renal or hepatic impairment: if total daily dose of at least 2mg of oral risperidone tolerated, may give 12.5mg or 25mg IM every 2 weeks. History of poor tolerability to psychotropic drugs or drug ...
Amneal has received the Food and Drug Administration’s approval of risperidone extended-release injectable suspension 12.5 mg/vial, 25 mg/vial, 37.5 mg/vial and 50 mg/vial, which is the generic of ...
WALTHAM, Mass., July 10 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Janssen's Risperdal ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Weekly risperidone delivered via the Lynx platform ...
Risperidone belongs to the group of medications known as antipsychotic agents. These medications are used to treat mental and emotional disorders such as schizophrenia and bipolar disorder.
A judge on Friday took an axe to a legal award against Johnson & Johnson — chopping the settlement from $8 billion to $6.8 million — in the case of a man who said the company failed to warn consumers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results